Abstract |
The aim of this study was to evaluate the effects of acarbose on inflammatory biomarkers and insulin resistance in diabetic patients before and after a standardized oral fat load (OFL). Ninety six patients were assigned to take acarbose 50mg three times a day and 92 to take placebo; after the first month acarbose was titrated to 100mg three times a day. We evaluated the following parameters at the baseline, and after 1, 2 and 7months: body mass index (BMI), glycemic control, fasting plasma insulin, post-prandial plasma insulin, homeostasis model assessment insulin resistance index (HOMA-IR), blood pressure, lipid profile, soluble intercellular adhesion molecule-1 (sICAM-1), interleukin-6 (IL-6), high-sensitivity C reactive protein ( Hs-CRP), soluble vascular cell adhesion molecule-1 (sVCAM-1), and soluble E-selectin (sE- selectin). Furthermore, at the baseline and at the end of the study all patients underwent OFL, and an euglycemic hyperinsulinemic clamp to evaluate M value and total glucose requirement. Acarbose was better than placebo in improving glycemic and lipid profile, and HOMA-IR. Furthermore, acarbose gave a decrease of fasting plasma insulin, post-prandial insulin, s-ICAM-1, sVCAM-1, IL-6, and Hs-CRP, not observed with placebo, even if no significant differences between the two groups were observed. During the second OFL performed after the therapy with acarbose, we observed a significant decrease of all inflammatory parameters' peaks compared to the OFL administered at baseline. Acarbose was more effective than acarbose in reducing the post-OFL peaks of the various parameters included the inflammatory markers, after 7months of therapy.
|
Authors | Giuseppe Derosa, Pamela Maffioli, Ilaria Ferrari, Elena Fogari, Angela D'Angelo, Ilaria Palumbo, Sabrina Randazzo, Lucio Bianchi, Arrigo F G Cicero |
Journal | European journal of pharmacology
(Eur J Pharmacol)
Vol. 651
Issue 1-3
Pg. 240-50
(Jan 25 2011)
ISSN: 1879-0712 [Electronic] Netherlands |
PMID | 21118681
(Publication Type: Journal Article, Multicenter Study, Randomized Controlled Trial)
|
Copyright | Copyright © 2010 Elsevier B.V. All rights reserved. |
Chemical References |
- Blood Glucose
- Dietary Fats
- Hypoglycemic Agents
- Acarbose
|
Topics |
- Acarbose
(pharmacology, therapeutic use)
- Blood Glucose
(metabolism)
- Blood Pressure
(drug effects)
- Body Mass Index
- Body Weight
(drug effects)
- Dietary Fats
(pharmacology)
- Female
- Humans
- Hypoglycemic Agents
(pharmacology, therapeutic use)
- Inflammation
(blood, drug therapy, metabolism, physiopathology)
- Insulin Resistance
(physiology)
- Lipid Metabolism
(drug effects)
- Male
- Middle Aged
|